Novo Nordisk-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2022

  1. Once-Weekly Semaglutide Use in Patients with Type 2 Diabetes: Results from the SURE Spain Multicentre, Prospective, Observational Study

    Journal of Clinical Medicine, Vol. 11, Núm. 17

2018

  1. Targets and teamwork: Understanding differences in pediatric diabetes centers treatment outcomes

    Pediatric Diabetes, Vol. 19, Núm. 3, pp. 559-565

2013

  1. Lessons from the Hvidoere International Study Group on childhood diabetes: Be dogmatic about outcome and flexible in approach

    Pediatric Diabetes, Vol. 14, Núm. 7, pp. 473-480

2010

  1. Target setting in intensive insulin management is associated with metabolic control: The Hvidoere Childhood Diabetes Study Group Centre Differences Study 2005

    Pediatric Diabetes, Vol. 11, Núm. 4, pp. 271-278

2008

  1. Variation within the PPARG gene is associated with residual beta-cell function and glycemic control in children and adolescents during the first year of clinical type 1 diabetes

    Pediatric Diabetes, Vol. 9, Núm. 4 PART 1, pp. 297-302

2007

  1. Improvement in growth after two years of growth hormone therapy in very young children born small for gestational age and without spontaneous catch-up growth: Results of a multicenter, controlled, randomized, open clinical trial

    Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 8, pp. 3095-3101

2005

  1. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation

    Liver Transplantation, Vol. 11, Núm. 8, pp. 973-979